Shain Howard, DO
Orthopaedic Surgery · Las Vegas, NVNPI 1891172441
Payments from drug & device makers
What this record shows
The money is spread across several categories — education (55.5%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. Goode Surgical Inc accounts for 61.8% of it on its own, with 18 other manufacturers making up the rest. Reporting peaked in 2019 at $11,756 and has fallen 93.9% since, to $718 in 2025.
Across 105 payments — averaging $198.70 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Goode Surgical Inc$13K
- Smith+Nephew$2K
- Stryker$1K
- Medical Device Business Services, Inc.$1K
- Arthrex$787
- Zimmer Biomet$426
- plus $2K from 13 others
What the payments were for
- Travel & lodging$2,95114%
- Food & beverage$6,33630%
- Education$11,57655%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Goode Surgical Inc | 20 | $12,884 |
| Smith+Nephew | 27 | $1,949 |
| Stryker | 18 | $1,374 |
| Medical Device Business Services, Inc. | 1 | $1,341 |
| Arthrex | 11 | $787 |
| Zimmer Biomet | 4 | $426 |
| Si-bone, Inc. | 3 | $336 |
| Johnson & Johnson | 3 | $256 |
| Osteocentric Technologies, Inc. | 4 | $253 |
| Medtronic | 2 | $251 |
| Skeletal Dynamics Inc | 2 | $169 |
| Organogenesis Inc. | 2 | $160 |
| Pacira Pharmaceuticals Incorporated | 1 | $122 |
| Amgen | 1 | $122 |
| Linvatec Corporation | 1 | $118 |
| DJO, LLC | 1 | $113 |
| KCI USA, Inc. | 1 | $100 |
| Aroa Biosurgery Incorporated | 2 | $69 |
| Sanara Medtech Inc. | 1 | $35 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$20,863 in reported general payments places this provider in the 75th percentile of 135 orthopaedic surgery providers in Nevada.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Diclofenac Sodium | 17 | $751 |
| Celecoxib | 55 | $734 |
| Ibuprofen | 68 | $481 |
| Oxycodone Hcl | 35 | $247 |
| Gabapentin | 31 | $201 |
| Tramadol Hcl | 31 | $109 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Las Vegas
- Mark BarryLas Vegas$9.5M
- Erik KubiakLas Vegas$7.8M
- Russell NevinsLas Vegas$1.5M
- Vladimir SinkovLas Vegas$434K
- Ronald HillockLas Vegas$275K
- Galen KamLas Vegas$270K
- Michael DaubsLas Vegas$215K
- John BaldaufLas Vegas$117K
- Brian CarrLas Vegas$91K
- Brandon RomeroLas Vegas$72K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.